{'fraction_non_alphanumeric': 0.02988338192419825, 'fraction_numerical': 0.021137026239067054, 'mean_word_length': 5.507109004739337, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Melatonin prevents the injury‐induced decline of Akt/forkhead transcription factors phosphorylation

Abstract:  Melatonin plays a neuroprotective role against brain injury through the activation of Akt and the inhibition of apoptotic cell death. This study investigated whether melatonin modulates the anti‐apoptotic signal through the activation of Akt and its downstream targets, FKHR, AFX, and 14‐3‐3. Adult male rats were treated with melatonin (5 mg/kg) prior to middle cerebral artery occlusion (MCAO) and brain tissues were collected at 24 hr after MCAO. This study confirmed that melatonin significantly reduces infarct volume and decreases the number of TUNEL‐positive cells in the cerebral cortex. Potential activation was measured by phosphorylation of PDK1 at Ser241, Akt at Ser473, FKHR at Ser256, and AFX at Ser193 using Western blot analysis. Melatonin prevented the injury‐induced reduction of pPDK1, pAkt, pFKHR, and pAFX. However, melatonin did not affect the level of 14‐3‐3, which acts as an anti‐apoptotic factor through interaction of pFKHR. Further, in the presence of melatonin, the interaction of pFKHR and 14‐3‐3 increased, compared with that of control animals. This study suggests that melatonin plays a potent protective role against brain injury and that Akt activation and FKHR phosphorylation by melatonin mediated these protective effects.